Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients-Reference-Cited by-同舟云学术

Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients

Published:2005-07 Issue:7 Volume:16 Page:1081-1086
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Cortes-Funes H.,Gomez C.,Rosell R.,Valero P.,Garcia-Giron C.,Velasco A.,Izquierdo A.,Diz P.,Camps C.,Castellanos D.,Alberola V.,Cardenal F.,Gonzalez-Larriba J.L.,Vieitez J.M.,Maeztu I.,Sanchez J.J.,Queralt C.,Mayo C.,Mendez P.,Moran T.,Taron M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/16/7/1081/398539/mdi221.pdf

Reference21 articles.

1. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer;Popanda;Carcinogenesis,2004

2. A bull's eye for targeted lung cancer therapy;Minna;Science,2004

3. Mutations and addiction to EGFR: the Achilles ‘heal’ of lung cancers?;Gazdar;Trends Mol Med,2004

4. Gefitinib (ZD1839) monotherapy as a salvage regimen for previously treated advanced non-small cell lung cancer;Park;Clin Cancer Res,2004

5. Mutational analysis of the tyrosine kinome in colorectal cancers;Bardelli;Science,2003

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2023

2. Mutational Analysis of EGFR Mutations in Non-Small Cell Lung Carcinoma—An Indian Perspective of 212 Patients;International Journal of Environmental Research and Public Health;2022-12-31

3. Disparate Time-to-Treatment and Varied Incidence of Actionable Non-Small Cell Lung Cancer Molecular Alterations in British Columbia: A Historical Cohort Study;Current Oncology;2022-12-22

4. Evaluating Real World Mutational Differences Between Hispanics and Asians in NSCLC at a Large Academic Institution in Los Angeles;Clinical Lung Cancer;2022-11

5. Single-cell RNA sequencing and bioinformatics as tools to decipher cancer heterogenicity and mechanisms of drug resistance;Biochemical Pharmacology;2022-01